Live Feeds
● LIVE Updated 2h ago · 17 sources tracked

Walmart settles lawsuit over painkiller prescriptions

Walmart will pay $50 million to resolve allegations from the Department of Justice and the Drug Enforcement Administration that its pharmacies unlawfully dispensed opioids and controlled substances. The federal government claimed Walmart filled thousands of prescriptions lacking a legitimate medical purpose starting in June 2013. As part of the deal, the retailer must implement safeguards to prevent further prescription abuse. This settlement concludes a legal battle where the government previously sought billions in civil penalties.

RSS Source map (17)

What changed

Details emerged that the settlement resolves claims involving prescriptions lacking legitimate medical purpose and follows previous government threats of billion-dollar penalties.

Live updates

  1. Walmart pays $50 million to settle federal opioid prescription lawsuit

    Walmart will pay $50 million to resolve allegations from the Department of Justice and the Drug Enforcement Administration that its pharmacies unlawfully dispensed opioids and controlled substances. The federal government claimed Walmart filled thousands of prescriptions lacking a legitimate medical purpose starting in June 2013. As part of the deal, the retailer must implement safeguards to prevent further prescription abuse. This settlement concludes a legal battle where the government previously sought billions in civil penalties.

    Why it matters

    The lawsuit alleged that Walmart's compliance structure ignored warnings from its own pharmacists who had flagged suspicious prescriptions. These failures allegedly contributed to the nationwide opioid epidemic. The case was brought under the Controlled Substances Act.

    What is confirmed

    • Walmart agreed to pay $50 million to settle a U.S. government lawsuit regarding the unlawful dispensing of opioid prescriptions.
    • The Department of Justice and the Drug Enforcement Administration brought claims that Walmart filled thousands of prescriptions for opioids and other controlled substances not issued for legitimate medical purposes.
    • The government alleged that the pharmacy violations began in June 2013.
    • Walmart must implement safeguards to prevent prescription abuse.

    Still unconfirmed

    • Walmart pharmacists identified suspicious prescriptions and submitted thousands of refusal-to-fill forms that the company's compliance structure failed to address.

    What to watch next

    • Details on the specific safeguards Walmart must implement to prevent prescription abuse
    • Reports on the effectiveness of the new DEA compliance monitoring requirements
    Sources used for this update (5)
    1. www.texarkanagazette.com — Walmart settles U.S. government's opioid lawsuit, which sought billions, for $50 million
    2. www.financial-world.org — Walmart agrees to $50 million opioid prescription settlement
    3. www.supermarketnews.com — Walmart settles federal opioid lawsuit for $50M
    4. 247wallst.com — Walmart Settled One of Its Ugliest Lawsuits for 0.4% of Six-Month Profit
    5. www.yahoo.com — Department of Justice settles with Walmart for $50 million over unlawful opioid prescriptions
    confidence 100%

  2. Walmart settles US opioid lawsuit for $50 million

    Walmart has agreed to pay $50 million to settle a US government lawsuit alleging its pharmacies unlawfully dispensed opioid prescriptions, contributing to the opioid epidemic. The settlement resolves allegations that Walmart pharmacies filled thousands of invalid opioid and controlled substance prescriptions since 2013. The deal includes a new DEA compliance agreement with reporting and monitoring requirements.

    Why it matters

    The lawsuit, filed in 2020, claimed Walmart pharmacies dispensed opioids and other controlled substances unlawfully. The settlement brings closure to a case that sought billions in damages. The opioid epidemic has been a major public health concern in the US.

    What is confirmed

    • Walmart agreed to pay $50 million to resolve DOJ and DEA allegations.
    • The settlement includes a new DEA compliance agreement with reporting and monitoring requirements.
    • The lawsuit alleged Walmart pharmacies dispensed opioids and other controlled substances unlawfully starting in 2013.

    What to watch next

    • Implementation of the DEA compliance agreement
    • Potential impact on Walmart's pharmacy practices
    • Further developments in the US opioid epidemic
    Sources used for this update (5)
    1. dailyhodl.com — Walmart Is Paying $50,000,000 To Settle DOJ Claims Over Opioid Prescriptions Lawsuit
    2. www.businesstimes.com.sg — Walmart settles US government’s opioid lawsuit, which sought billions, for US$50 million
    3. www.yahoo.com — Walmart settles DOJ opioid crisis lawsuit for $50 million
    4. anewz.tv — Walmart settles U.S. opioid lawsuit over pharmacy practices
    5. www.fox10phoenix.com — Walmart agrees to pay $50M settlement over allegations its pharmacies filled illegal opioid prescriptions
    confidence 100%

  3. Walmart pays $50 million to settle federal opioid lawsuit

    Walmart will pay $50 million to settle a U.S. government lawsuit alleging the company fueled the opioid epidemic by unlawfully dispensing prescriptions. The Justice Department filed the suit in 2020, claiming Walmart pharmacies dispensed opioids and other controlled substances unlawfully starting in 2013. Associate Attorney General Stanley Woodward stated that profit does not justify conduct that fuels the opioid crisis and that federal pharmacy rules are designed to protect the public.

    Why it matters

    This settlement addresses pharmacy practices that allegedly bypassed federal safety rules. The case highlights the role of large retailers in the nationwide distribution of controlled substances.

    What is confirmed

    • Walmart settled a U.S. government lawsuit for $50 million.
    • The Justice Department sued Walmart in 2020.
    • The government alleged Walmart pharmacies unlawfully dispensed opioids and other controlled substances since 2013.
    • The lawsuit accused Walmart of fueling a nationwide opioid epidemic.

    What to watch next

    • Details on whether the settlement includes mandated changes to pharmacy oversight practices
    • Potential impact on Walmart stock prices following the settlement announcement
    Sources used for this update (9)
    1. Financial Times — Walmart settles lawsuit over painkiller prescriptions
    2. CNBC — Walmart settles U.S. government's opioid lawsuit
    3. CBS News — Walmart settles Justice Department lawsuit over unlawfully dispensing opioids
    4. qz.com — Walmart settles federal opioid lawsuit over pharmacy practices
    5. USA Today — Walmart reaches settlement in DOJ opioid case. What to know
    6. www.yahoo.com — Walmart settles federal opioid lawsuit over pharmacy practices
    7. www.arkansasonline.com — Walmart settles U.S. government's opioid lawsuit
    8. journalrecord.com — Walmart settles federal lawsuit over role in opioid epidemic
    9. finance.yahoo.com — Walmart To Pay $50M To Settle DOJ Lawsuit Over Invalid Opioid Prescriptions — WMT Stock In Focus
    confidence 100%